missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ C10orf97 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA558381
This item is not returnable.
View return policy
Description
Immunogen sequence: VSNVWDGDRE CSGMKLLGIH EQAAVGFLTL MEALRYCKVG SYLKSPKFPI WIVGSETHLT VFFAKDMALV APEAPSEQAR RVFQTYDPED NGFIPDSLLE DVM Highest antigen sequence identity to the following orthologs: Mouse - 98%, Rat - 96%.
The protein encoded by this gene contains a caspase-associated recruitment domain and may function in apoptosis. It has been identified as a tumor suppressor in lung and gastric cancers, and a polymorphism in the gene may be associated with gastric cancer risk. Alternative splicing of this gene results in multiple transcript variants.
Specifications
| C10orf97 | |
| Polyclonal | |
| Unconjugated | |
| MINDY3 | |
| 1810041E18Rik; 2310047O13Rik; 5830410F13Rik; AI447827; AW111958; C10orf97; CARD-containing protein; Carp; caspase recruitment domain containing pro-apoptotic protein; caspase recruitment domain containing protein; dermal papilla-derived protein 5; DERP5; Deubiquitinating enzyme MINDY-3; Fam188a; family with sequence similarity 188 member A; family with sequence similarity 188, member A; MINDY3; MST126; MSTP126; My042; Protein CARP; protein FAM188A; RGD1309605; RP11-394I23.1; Ubiquitin carboxyl-terminal hydrolase MINDY-3 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 80013 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 0.4 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q9H8M7 | |
| MINDY3 | |
| Recombinant protein corresponding to Human C10orf97. Recombinant protein control fragment (Product #RP-97099). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction